Filana Therapeutics, Inc. (FLNA)
NASDAQ · Healthcare
Filana Therapeutics, Inc. Revenue 2009–2013
Filana Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2009 to 2013. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Filana Therapeutics, Inc. revenue for the quarter ending September 30, 2013 was 2.0 M, a 28.15% decrease year-over-year.
- Filana Therapeutics, Inc. revenue for the twelve months ending September 30, 2013 was 8.6 M, a 23.20% decrease year-over-year.
- Filana Therapeutics, Inc. annual revenue for 2013 was 41.1 M, a 277.58% increase from 2012.
- Filana Therapeutics, Inc. annual revenue for 2012 was 10.9 M, a 5.17% decrease from 2011.
- Filana Therapeutics, Inc. annual revenue for 2011 was 11.5 M, a 31.68% decrease from 2010.
- Filana Therapeutics, Inc. annual revenue for 2010 was 16.8 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Filana Therapeutics, Inc. Market Cap — FAQ
Filana Therapeutics, Inc. (FLNA) market cap over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FLNA's market cap history?
The chart and table above show Filana Therapeutics, Inc.'s market cap by year and by quarter, including the growth rate.